Etges T, Karolia K, Grint T, Taylor A, Lauder H, Daka B, & Wright S. (2016). An observational postmarketing safety registry of patients in the UK, Germany, and Switzerland, who have been prescribed Sativex® (THC: CBD, nabiximols) oromucosal spray. Dove Medical Press.
Chicago Style (17th ed.) CitationEtges T, Karolia K, Grint T, Taylor A, Lauder H, Daka B, and Wright S. An Observational Postmarketing Safety Registry of Patients in the UK, Germany, and Switzerland, Who Have Been Prescribed Sativex® (THC: CBD, Nabiximols) Oromucosal Spray. Dove Medical Press, 2016.
MLA (9th ed.) CitationEtges T, et al. An Observational Postmarketing Safety Registry of Patients in the UK, Germany, and Switzerland, Who Have Been Prescribed Sativex® (THC: CBD, Nabiximols) Oromucosal Spray. Dove Medical Press, 2016.